Apothecary Pharma, a drug compounder in Cary, North Carolina, is recalling 22 vials of compounded tirzepatide distributed nationwide because their sterility cannot be assured. The recall also includes one vial of an NAD+ injection, and no illnesses or injuries have been reported, according to the FDA recall notice summarized by LiveNOW from FOX.
Tirzepatide is the active ingredient in Mounjaro and Zepbound. Compounded versions are not FDA-approved, but many people buy them through clinics and telehealth programs because they often cost less than the brand-name drugs.
